VIEWS AND ANALYSIS, PHARMA TECH

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

June 28, 2022

How Specialty Pharmacy
CF is a rare, autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene that encodes the CFTR protein, an anion channel normally present in the epithelial membrane.1,2

Spotlight

AOP Orphan Pharmaceuticals AG

AMOMED Pharma GmbH is a member of the AOP Orphan Group and based in Vienna, Austria. Since our establishment in 2006, we have grown into a renowned specialist for intensive care and emergency medicine. Over the next years, we are determined to become a major player in these fields in Europe

OTHER WHITEPAPERS
news image

Adapting to Pharma’s Next Normal

whitePaper | October 4, 2022

Let’s just say what we’re all thinking: 2020 was rough. It threw every element of our lives into disarray. We suddenly had to become experts at navigating a new way of working, schooling and socialising. It was disruptive and it was challenging, but it was also transformative

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More
news image

Expediting early-phasedevelopment ofsmall molecules: Anintegrated approach

whitePaper | November 18, 2022

Small molecule drug development has changed substantially in recent years. With the heightened focus on molecularly targeted therapies, small molecule active pharmaceutical ingredients (APIs).

Read More
news image

Nanoform Management Presentation

whitePaper | May 24, 2022

Our proprietary nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics.

Read More
news image

Empowering MSLs to be the kings of Pharma’s New Frontier

whitePaper | December 12, 2022

To improve outcomes for cancer patients and take advantage of the groundbreaking scientific and technological progress made in oncology prevention, diagnosis, therapy

Read More
news image

The true impact of machine failure in pharma

whitePaper | November 24, 2022

Today’s pharmaceutical industry is facing big expectations and opportunities. Tasked with developing and manufacturing effective therapeutics and vaccines for an ongoing global pandemic,

Read More

Spotlight

AOP Orphan Pharmaceuticals AG

AMOMED Pharma GmbH is a member of the AOP Orphan Group and based in Vienna, Austria. Since our establishment in 2006, we have grown into a renowned specialist for intensive care and emergency medicine. Over the next years, we are determined to become a major player in these fields in Europe

Events